• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

acquired thrombotic thrombocytopenic purpura (aTTP) - Articles and news items

Ablynx starts Phase III follow-up aTTP study

Industry news / 13 October 2016 / Niamh Louise Marriott, Digital Content Producer

Acquired TTP is an acute, ultra-rare, life-threatening blood clotting disorder in which uncontrolled platelet aggregation and microclot formation cause…

 

Webinar: NIR Spectroscopy for Assessing Blend Uniformity in the Pharmaceutical IndustryLEARN MORE
+ +